|
Washington, Nov 18 : Canadian researchers claim to have found an answer to why some former smokers develop lung cancer, while others don't - despite similar lifestyle changes.
|
|
... Taxotere and Docetaxel Winthrop were expected to be used for the adjuvant treatment of patients with operable breast cancer whose tumours overexpress HER2 in the following combinations: in combination (given simultaneously) with trastuzumab ...
|
|
Main Category: Lung Cancer Also Included In: Respiratory / Asthma ; Cancer / Oncology Article Date: 18 Nov 2008 - 3:00 PST A new Australian study has found that extending the use of chemotherapy in patients ...
|
|
... SA (PAR: 12057) of the latter's decision to withdraw its application for an extension of indication for its cancer drugs Taxotere and Docetaxel Winthrop. The company stated that the withdrawal is based on the Committee for Medicinal Products for ...
|
|
LONDON and CAMBRIDGE, MA-- - Cancer drug developer Antisoma plc holds its AGM today and provides an update on its key pipeline products and other corporate developments.
|
|
jbhiatt dermpaper Abstract BRAF encodes a RAS-regulated kinase that mediates cell growth and malignant transformation kinase pathway activation. Recently, we have identified activating BRAF mutations in 66% of melanomas and a smaller percentage of ...
|
|
Country legend Merle Haggard is resting comfortably at his home in Bakersfield, Calif., following recent surgery to have a malignant tumor removed from his lung.
|
|
The four drug-combination of carboplatin and paclitaxel, with the targeted therapies bevacizumab and cetuximab , is safe and may improve survival for patients with advanced lung cancer, according to a ...
|
|
Lung Cancer Genetics Different in Black Patients, Case Western Reserve University , University of Colorado And Instituto Clinico Humanitas IRCCS Study 11/17/2008 ScienceDaily a ' The tumors of African-American ...
|
|
The combination of traditional chemotherapy agents with targeted therapies called monoclonal antibodies showed no safety concerns and improved survival in patients with advanced non-small cell lung cancer ...
|
|
First Pivotal Trials Begin For Boehringer Ingelheim's Novel Triple Angiokinase Inhibitor Vargatef Main Category: Lung Cancer Also Included In: Respiratory / Asthma ; Cancer / Oncology ; Clinical Trials / Drug ...
|
|
... (Iressa; AstraZeneca, Mississisauga, Ontario, Canada). Report of a Case A 70-year-old woman with stage IV non-small cell lung cancer was evaluated regarding a 2-year history of scalp erythema and crusting that progressed to scarring alopecia (Figure ...
|